<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>siRNA therapy** &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/sirna-therapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 12 Jan 2026 04:32:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>siRNA therapy** &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Enhanced Tumor Immunotherapy via Targeted Nanoparticles</title>
		<link>https://bioengineer.org/enhanced-tumor-immunotherapy-via-targeted-nanoparticles/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 12 Jan 2026 04:32:40 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **immunotherapy]]></category>
		<category><![CDATA[siRNA therapy**]]></category>
		<category><![CDATA[targeted nanoparticles]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<category><![CDATA[VEGF/PD-L1 inhibition]]></category>
		<guid isPermaLink="false">https://bioengineer.org/enhanced-tumor-immunotherapy-via-targeted-nanoparticles/</guid>

					<description><![CDATA[In recent years, enhancing cancer immunotherapy has emerged as one of the leading fields of research in oncology. The emergence of novel therapeutic agents designed to remodel the tumor microenvironment is pivotal for overcoming tumor resistance mechanisms and improving overall therapeutic efficacy. A groundbreaking study by Li et al. has taken significant strides towards this [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">315972</post-id>	</item>
	</channel>
</rss>
